F-D-C Reports
Where biomedical industry professionals turn for news, insight and analysis
FDC Reports, an industry-leader since 1939, is vital to top pharmaceutical and healthcare executives, policy-makers, and analysts who need to make the most of opportunities and challenges affecting the regulation and marketing of healthcare products and services.
Trust the largest team of journalists dedicated exclusively to your industry
Our highly experienced and respected editorial teams report on the latest regulatory, legislative, and business news affecting the drug, biotechnology, medical device, non-prescription drug, nutritionals, and cosmetics industries.
Our publications:
- "The Pink Sheet" - Top down, comprehensive weekly industry insight and analysis
- "The Pink Sheet" DAILY - Immediate business intelligence from the company and product level up
- "The Gray Sheet" - Comprehensive weekly news and analysis for medical device professionals
- "The Tan Sheet" - The OTC industry’s leading weekly source of business and regulatory news and analysis
- "The Rose Sheet" - In-depth weekly news and analysis about the cosmetics, fragrances and skin care industries
- "The Gold Sheet" - Monthly news and analysis to help you comply with pharmaceutical manufacturing QA/QC requirements in the U.S. and internationally
- "The Silver Sheet" - Monthly news and analysis to help you comply with pharmaceutical manufacturing QA/QC requirements in the medical device and diagnostics industries
- "Pharmaceutical Approvals Monthly" - In-depth, monthly look at the U.S. drug and biologic approval process
- "Health News Daily" - Daily overview of the biomedical industry
An Elsevier company
FDC Reports is part of Elsevier, a world-leading publisher of scientific, technical and medical information products and services.
Contact us
F-D-C Reports, Inc.
5635 Fishers Lane, Suite 6000
Rockville, MD 20852
Toll free: 800-332-2181
Phone: 240-221-4500
mailto:fdc.customer.service@elsevier.com
